Apr 11, 2024

PDC*line Pharma Presents Interim Clinical Results From Last Cohort of Patients in Phase I/II Trial with PDC*lung01 Cancer Vaccine [AACR 2024]

›
Intermediary results of high dose PDC*lung01 combined with pembrolizumab show mild safety profile, immunological activity and promising tumo...
Feb 13, 2024

Sionna Therapeutics Announces Phase 1 Initiation for SION-109 in Cystic Fibrosis

›
– SION-109 is a small molecule targeting the interface between the ICL4 region and the NBD1 domain of the CFTR protein; designed to compleme...
Feb 7, 2024

NuvoAir’s Air Next Spirometer is FDA-approved for in-home use

›
The Air Next Spirometer was granted 510k approval for in-home use by the NuvoAir clinical team and its clinical trials partners. January 25t...
Jan 24, 2024

Thirona : LungQ 3.0.0 receives FDA 510(k) clearance

›
Nijmegen, the Netherlands (January 22nd, 2024) – Thirona, a global company specializing in advanced analysis of thoracic CT images with art...
Jan 16, 2024

Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer

›
Data update from AFM24-102 Phase 1/2a combination study includes 15 heavily pre-treated patients from the EGFR-wildtype (wt) non-small cell ...
Jan 8, 2024

European Medicines Agency Validates Bristol Myers Squibb’s Application for Repotrectinib for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer and NTRK-Positive Solid Tumors

›
Application based on data from the registrational TRIDENT-1 and CARE trials showing robust responses and durable activity in these patient p...
Dec 29, 2023

FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer

›
Currently There are no Approved Therapeutic Options for Third-Line Treatment of Advanced SCLC1 If Approved, Tarlatamab Would be the First Bi...
Nov 14, 2023

CorVista Health Announces AHA Presentation of Machine Learning to Detect Pulmonary Hypertension at Point-of-Care

›
Washington DC—November 12, 2023 — CorVista Health, Inc, a leading digital health company dedicated to improving cardiovascular disease diag...
Nov 21, 2012

Ampliphi Biosciences : Encouraging Pre-Clinical Data on the Use of Phage-Based Therapies to Treat Bacterial Lung Infections

›
October 18, 2012 - AmpliPhi Biosciences Corporation (APHB.PK) [‘AmpliPhi’] presented encouraging data from a pre-clinical animal model st...
May 21, 2012

Chugai Pharmaceutical : Approval of an Orphan Drug, “Pulmozyme®,” a Recombinant Human Deoxyribonuclease I (rhDNase)

›
March 30, 2012 (Tokyo) - Chugai Pharmaceutical Co., Ltd. [Main Office: Chuo-ku, Tokyo. Chairman & CEO: Osamu Nagayama (hereafter, “Ch...
Apr 24, 2012

Synairgen : Positive Phase II asthma clinical trial data

›
April 19, 2012 - Synairgen plc (LSE: SNG) , announces positive data from its Phase II clinical trial. This pioneering trial investigated...
Apr 4, 2012

Almirall and Menarini : licence agreement and commercial alliance for Aclidinium in the majority of European member states and a number of non-EU countries

›
26 March 2012 - Almirall and Menarini sign a licence agreement and commercial alliance for Aclidinium in the majority of European member s...
Mar 21, 2012

Covidien : Definitive Agreement to Acquire superDimension, Ltd.

›
Mar. 19, 2012-- Covidien (NYSE: COV) , a leading global provider of healthcare products, announced a definitive agreement to acquire super...
Mar 13, 2012

PhRMA : More Than 70 Medicines in Development for Asthma

›
March 5, 2012 — America’s biopharmaceutical research companies are developing 74 medicines to treat or prevent asthma , according to a rep...